华熙生物科技股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告

Core Viewpoint - The announcement details a reduction in shareholding by a significant shareholder, Guoshou Chengda, which has decreased its stake in Huaxi Biological Technology Co., Ltd. from 6.01% to 5.89% through the sale of 571,782 shares, touching the 1% threshold for disclosure [1][2]. Group 1 - The shareholder Guoshou Chengda has reduced its holdings from 28,936,504 shares to 28,364,722 shares, representing a decrease of 571,782 shares [1]. - The reduction in shareholding is part of a previously disclosed plan and does not trigger a mandatory tender offer [2]. - This change in shareholding will not affect the actual control of the company or its governance structure [2]. Group 2 - The company emphasizes that the shareholder's actions comply with relevant laws and regulations, including the Securities Law of the People's Republic of China [2]. - The company will continue to monitor compliance and ensure timely disclosure of relevant information to investors [2]. - The announcement was made by the board of directors of Huaxi Biological Technology Co., Ltd. on November 28, 2025 [3].